BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 32011436)

  • 1. Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis.
    Zhu Y; Zhang H; Chen N; Hao J; Jin H; Ma X
    Medicine (Baltimore); 2020 Jan; 99(3):e18581. PubMed ID: 32011436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: A meta-analysis.
    Zhu Y; Yang T; Wu Q; Yang X; Hao J; Deng X; Yang S; Gu C; Wang Z
    Cancer Med; 2020 Aug; 9(16):5699-5707. PubMed ID: 32628360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of S100P for pancreatic cancer: a meta-analysis.
    Hu H; Zhang Q; Huang C; Shen Y; Chen X; Shi X; Tang W
    Tumour Biol; 2014 Oct; 35(10):9479-85. PubMed ID: 25123266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
    Creemers A; Krausz S; Strijker M; van der Wel MJ; Soer EC; Reinten RJ; Besselink MG; Wilmink JW; van de Vijver MJ; van Noesel CJM; Verheij J; Meijer SL; Dijk F; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):394-403. PubMed ID: 28801248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of circulating tumor cells for lung cancer: A systematic review and meta-analysis.
    Ye Y; Li SL; Wang JJ; Liu B
    Medicine (Baltimore); 2019 Mar; 98(12):e14936. PubMed ID: 30896658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.
    Wang K; Wang X; Pan Q; Zhao B
    Mol Cancer; 2023 Oct; 22(1):167. PubMed ID: 37803304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of blood-based liquid biopsies in hepatocellular carcinoma: A protocol for systematic review and meta-analysis.
    Zhang T; Yin M; Wang L; Cao W; Zhong S
    Medicine (Baltimore); 2020 Oct; 99(41):e22594. PubMed ID: 33031312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsies in thyroid cancers: a systematic review and meta-analysis.
    Zeyghami W; Hansen MU; Jakobsen KK; Groenhøj C; Feldt-Rasmussen U; von Buchwald C; Hahn CH
    Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37882489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 11. The diagnostic value of circulating tumor cells and ctDNA for gene mutations in lung cancer.
    Lyu M; Zhou J; Ning K; Ying B
    Onco Targets Ther; 2019; 12():2539-2552. PubMed ID: 31040697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of circulating lncRNAs as biomarkers of digestive system cancers: A systematic review and meta-analysis.
    Fang X; Wang D; Pu K; Zhang Z; Wang H; Wang H; Zheng Y; Wang Y; Guan Q; Zhou Y
    Expert Rev Mol Diagn; 2020 Oct; 20(10):1051-1062. PubMed ID: 33138648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies.
    Yang Y; Yan S; Tian H; Bao Y
    Medicine (Baltimore); 2018 Mar; 97(9):e9994. PubMed ID: 29489701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
    Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
    Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel blood-based microRNA biomarkers for diagnosis of pancreatic cancer: a meta-analysis.
    Meng QC; Qiu WW; Wen ZQ; Wang HC; Shan ZZ; Yuan Z; Huang XY
    Tumori; 2015; 101(2):199-205. PubMed ID: 25838251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.
    Fang Z; Meng Q; Zhang B; Shi S; Liu J; Liang C; Hua J; Yu X; Xu J; Wang W
    Aging (Albany NY); 2020 Dec; 13(2):2031-2048. PubMed ID: 33318293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
    Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
    Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of diagnostic value of serum Carbohydrate antigen 199 in pancreatic cancer.
    Zhang Y; Jiang L; Song L
    Minerva Med; 2016 Feb; 107(1):62-9. PubMed ID: 26824636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTC, ctDNA, and Exosome in Thyroid Cancers: A Review.
    Wang W; Zheng Z; Lei J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.